EUVIMEDEUVIMED entdecken
Crossref

Achievement of LDL cholesterol targets in HIV-positive patients

Michela Algeri, Alessandro Maloberti, Antonio Delle Cave, Marco Bellomare, Chiara Tognola, Vittorio Tateo, Maria Chiara Pedretti, Paolo Ossola, Cristina Giannattasio, Massimo Puoti

European Atherosclerosis Journal · 30.04.2026 · 5 (1) · 21

DOI: 10.56095/eaj.v5i1.128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Atherosclerosis Journal, online erschienen am 30.04.2026. Verfasst von Michela Algeri und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives: People living with HIV (PLWH) face an increased cardiovascular (CV) risk due to the interaction of traditional risk factors, chronic inflammation and cumulative antiretroviral therapy (ART) adverse metabolic effects. However, standard risk models often underestimate this burden, limiting effective prevention. This study evaluates LDL cholesterol target achivement in PLWH, based on European Society of Cardiology guidelines, and explores its association with clinical, immunological, and therapeutic HIV-related variables.

Methods

A retrospective analysis was conducted on 246 HIV-positive patients, aged ≥40, on ART at Niguarda Hospital. Clinical, laboratory, and therapeutic data were extracted from the hospital’s electronic registries, while ten-year CV risk was assessed using SCORE2 from which each patients LDL cholesterol target was defined.

Results

Only 27.2% of the analyzed cohort achieved the recommended LDL cholesterol targets; a significantly higher prevalence of uncontrolled profiles was observed among patients belonging to the “high” or “very high” SCORE2 risk categories (29.3 and 14.6% of the population, respectively). 35.4% of the patients take statins, 12.2% ezetimibe while only the l’11.4% take their association. Univariate analysis showed that lower value of total cholesterol (r=-0.490, p

Zitieren

APA

Algeri, M., Maloberti, A., Cave, A. D., Bellomare, M., Tognola, C., Tateo, V., Pedretti, M. C., Ossola, P., Giannattasio, C., & Puoti, M. (2026). Achievement of LDL cholesterol targets in HIV-positive patients. European Atherosclerosis Journal, 5(1), 21. https://doi.org/10.56095/eaj.v5i1.128

Vancouver

Algeri M, Maloberti A, Cave AD, Bellomare M, Tognola C, Tateo V, et al. Achievement of LDL cholesterol targets in HIV-positive patients. European Atherosclerosis Journal. 2026;5(1):21. doi:10.56095/eaj.v5i1.128

BibTeX
@article{Algeri2026,
  author = {Algeri, Michela and Maloberti, Alessandro and Cave, Antonio Delle and Bellomare, Marco and Tognola, Chiara and Tateo, Vittorio and Pedretti, Maria Chiara and Ossola, Paolo and Giannattasio, Cristina and Puoti, Massimo},
  title = {Achievement of LDL cholesterol targets in HIV-positive patients},
  journal = {European Atherosclerosis Journal},
  year = {2026},
  volume = {5},
  number = {1},
  pages = {21},
  doi = {10.56095/eaj.v5i1.128}
}
Kostenlos starten →